Multiple Nivolumab-Induced CNS Demyelination With Spontaneous Resolution in an Asymptomatic Metastatic Melanoma Patient

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0818-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Nivolumab-Induced Fulminant Autoimmune Diabetes Presenting as Diabetic Ketoacidosis in a Patient With Melanoma

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

CNS Demyelination With TNF-α Blockers

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2017English

Severe Hemophagocytic Lymphohistiocytosis in a Melanoma Patient Treated With Ipilimumab + Nivolumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Coronavirus-Induced Demyelination and Spontaneous Remyelination

2005English

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient With Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome

Case Reports in Oncological Medicine
Oncology
2018English

Influenza Vaccine-Induced CNS Demyelination in a 50-Year-Old Male

American Journal of Case Reports
Medicine
2014English

Recurrent Checkpoint Inhibitor-Induced Warm Agglutinin Autoimmune Hemolytic Anemia in a Patient With Metastatic Melanoma

American Journal of Hematology
Hematology
2020English

Successful Dabrafenib Transition After Vemurafenib-Induced Toxic Epidermal Necrolysis in a Patient With Metastatic Melanoma

JAAD Case Reports
Dermatology
2018English

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy